Zimmer Biomet (ZBH) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Zimmer Biomet Holdings, Inc. (ZBH) insider buying and selling: no purchases, 7 sales
58 Form 4 Table I transactions filed with the SEC by Zimmer Biomet Holdings, Inc. insiders between 2025-09-02 and 2026-10-05 (15-month history): 0 open-market purchases and 7 sales, plus 51 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $529k by Thornal Kevin R on 2026-09-11.
Zimmer Biomet insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Zimmer Biomet insiders filed 5 sales worth $1.6M on the open market, and no purchases.
The biggest seller was Thornal Kevin R (Grp Pres-Global Business): $529k in 1 sale, out of 4 different sellers.
The largest trade of the period was a sale of $529k on Sep 11, 2026, by Thornal Kevin R (Grp Pres-Global Business). Form 4 on sec.gov (0001783992-26-000006).
None of the 5 sales carries the 10b5-1 plan flag on the Form 4 (sales scheduled months ahead).
The last three months show 2 sales, against 1 in the three before. The latest sale from Sep 11, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Zimmer Biomet has more sales than 18 of the other 58, ranks 44 of 59 by net dollars sold, and 19 of the 59 have at least one purchase.
The 20 most important trades
With no open-market purchases, the table starts with ZBH's sales, largest first. The full history is in the tool above, already searched.
See all 58 ZBH trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-09-11 | 2026-09-15 | Thornal Kevin R | Grp Pres-Global Business | $529k | S — Open-market sale | SEC |
| 2026-05-29 | 2026-06-02 | Yi Sang | Group President, Asia Pacific | $413k | S — Open-market sale | SEC |
| 2026-09-04 | 2026-09-09 | Phipps Chad F | See remarks below. | $295k | S — Open-market saleForm 4 footnoteF1 Includes 471 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through July 31, 2026. | SEC |
| 2026-03-12 | 2026-03-16 | Winkler Lori | SVP and CHRO | $251k | S — Open-market sale | SEC |
| 2025-09-08 | 2025-09-10 | Winkler Lori | SVP and CHRO | $156k | S — Open-market saleForm 4 footnoteF1 Reflects the weighted average price of 1,500 common shares sold by the reporting person in multiple transactions on September 8, 2025 with sale prices ranging from $104.15 to $104.18 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. | SEC |
| 2025-09-11 | 2025-09-15 | Yi Sang | Group President, Asia Pacific | $124k | S — Open-market saleForm 4 footnoteF1 Includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025. | SEC |
| 2026-02-12 | 2026-02-17 | Yi Sang | Group President, Asia Pacific | $96k | S — Open-market saleForm 4 footnoteF1 Includes 86 shares acquired under the Employee Stock Purchase Plan on December 31, 2025. | SEC |
| 2026-03-06 | 2026-03-10 | Tornos Ivan | Chairman, President and CEO | $1.8M | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-02-25 | 2026-02-27 | Tornos Ivan | Chairman, President and CEO | $1.1M | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-02-20 | 2026-02-24 | Tornos Ivan | Chairman, President and CEO | $872k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-03-06 | 2026-03-10 | Upadhyay Suketu | Exec VP, CFO | $609k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2025-11-10 | 2025-11-12 | Upadhyay Suketu | Exec VP, CFO | $415k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of the restricted stock units ("RSUs"). | SEC |
| 2026-08-01 | 2026-08-04 | Thornal Kevin R | Grp Pres-Global Business | $395k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-02-25 | 2026-02-27 | Upadhyay Suketu | Exec VP, CFO | $282k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-03-06 | 2026-03-10 | Phipps Chad F | See remarks below. | $253k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-02-20 | 2026-02-24 | Upadhyay Suketu | Exec VP, CFO | $241k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-03-06 | 2026-03-10 | Winkler Lori | SVP and CHRO | $202k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-03-06 | 2026-03-10 | Van Zuilen Wilfred | Group Pres, EMEA | $169k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-04-01 | 2026-04-03 | Noor Jehanzeb | See remarks below. | $152k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF2 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding on the vesting of restricted stock units ("RSUs"). | SEC |
| 2026-10-01 | 2026-10-05 | Campbell Gary Craig | President, Americas | $125k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs"). | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Sep 2, 2025 and Oct 5, 2026 there is not one open-market purchase of Zimmer Biomet Holdings, Inc.: 7 sales worth $1.9M and zero dollars bought.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Zimmer Biomet Holdings, Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| M | Option exercise | 27 | $0 |
| F | Tax withholding (shares surrendered for taxes) | 24 | $7.3M |
| S | Open-market sale | 7 | $1.9M |
| Total | Everything filed in the period | 58 | $9.1M |
27 of the 58 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 10 distinct people or entities have filed Zimmer Biomet Holdings, Inc. transactions: none bought on the open market and 4 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Yi Sang | Group President, Asia Pacific | 6 | — | $634k (3) | 2026-06-02 |
| Thornal Kevin R | Grp Pres-Global Business | 3 | — | $529k (1) | 2026-09-15 |
| Winkler Lori | SVP and CHRO | 10 | — | $407k (2) | 2026-03-16 |
| Phipps Chad F | See remarks below. | 7 | — | $295k (1) | 2026-09-09 |
| Stellato Paul A | VP, Controller, CAO | 8 | — | — | 2026-03-10 |
| Upadhyay Suketu | Exec VP, CFO | 8 | — | — | 2026-03-10 |
| Tornos Ivan | Chairman, President and CEO | 6 | — | — | 2026-03-10 |
| Van Zuilen Wilfred | Group Pres, EMEA | 6 | — | — | 2026-03-10 |
Shown here are the 8 who moved the most money, out of 10. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Sep 2025: 0 purchases and 2 sales, worth $281k. 10 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 0 | $0 |
| Sep 2025 | 0 | $0 | 2 | $281k |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 0 | $0 | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 1 | $96k |
| Mar 2026 | 0 | $0 | 1 | $251k |
| Apr 2026 | 0 | $0 | 0 | $0 |
| May 2026 | 0 | $0 | 1 | $413k |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 0 | $0 |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 2 | $824k |
| Oct 2026 | 0 | $0 | 0 | $0 |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Zimmer Biomet Holdings, Inc. (ZBH) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
None of the 7 sales in the table is flagged as scheduled (10b5-1 plan), the kind signed months ahead and executed automatically. Zimmer Biomet has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Oct 5, 2026, and a Form 4 arrives up to two business days after the trade.
17 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.